Sandoz announces release of generic version of Sarafem capsules
PRINCETON, N.J. Novartis subsidiary Sandoz announced Tuesday that it launched a generic version of Eli Lilly and Co.’s Sarafem capsules.
The drug, known generically as fluoxeline hydrochloride, is used to treat mood changes and physical symptoms related to premenstrual dysphoric disorder. Up to 10 percent of menstruating women have PMDD.
The drug will be available in 10 mg and 20 mg strengths. Warner Chilcott markets Sarafem in tablet form. Fluoxetine hydrochloride is also the active ingredient in Lilly’s antidepressant Prozac.
King announces acquisition of Alpharma
BRISTOL, Tenn. King Pharmaceuticals will acquire Alpharma in a deal worth $1.6 billion, King said Monday.
Alpharma had rejected a $33-per-share bid King made earlier, but accepted the most recent $37-per-share bid.
Alpharma, based in Bridgewater, N.J., has lately sought regulatory approval for painkillers designed to thwart abuse, such as Remoxy, a liquid capsule-based formulation of oxycodone.
Viagra under investigation for effect on athletes
NEW YORK The World Anti-Doping Agency is investigating whether the drug Viagra gives athletes a competitive advantage on the playing field.
The drug, known generically as sildenafil citrate and made by Pfizer, works by opening the blood vessels. According to published reports, some experts have said this could give athletes more endurance by increasing the bloodstreams ability to deliver oxygen.
If studies indicate that Viagra does give athletes an advantage, WADA will consider listing it as a performance-enhancing drug.